The cost of photoselective vaporization of the prostate compared to transurethral resection of the prostate: Experience in a large public Australian teaching centre

Abstract

Objective:

The purpose of this study was to compare the cost of photoselective vaporization of the prostate (PVP) with transurethral resection of the prostate (TURP) in the treatment of men with bladder outflow obstruction (BOO).

Patients and methods:

Men underwent PVP or TURP for clinical BOO or urinary retention. We developed a cost framework to calculate the costs of theatre, recovery and ward time in our publically funded institution and calculated a cost for each procedure including the initial stay and any associated admissions over the first 60 days. These costs were statistically analyzed.

Results:

A total of 99 men underwent PVP and 97 had TURP. Groups were well matched for age and operative indication. The American Society of Anesthesia (ASA) grade was higher for the PVP group with more taking anticoagulants (36% versus 3.1%). PVP was 74% more expensive (median AUD$4243 vs AUD$2439, p<0.001) than TURP, even in a sub-set analysis excluding the anticoagulated patients. This was because of longer operating time and unavoidable disposable costs.

Conclusions:

Previous cost studies have all had significant flaws. Using our “bottom up” cost framework suggests that the unavoidable costs of purchasing a laser, single use laser fibers and other paraphernalia will almost always exceed the costs associated with in-patient stay. We caution against establishing a PVP service in a public hospital setting.

Keywords

Transurethral resection of the prostate photoselective vaporization of the prostate cost

Get full access to this article

View all access options for this article.

References

Malek

Kuntzman

Barrett

. High power potassium-titanyl-phosphate laser vaporization prostatectomy. J Urol 2000;163: 1730–1733.

Chandrasekera

Muir

. Potassium titanyl phosphate laser prostatectomy: A review. Curr Opin Urol 2007;17: 22–26.

Thangasamy

Chalasani

Bachman

. Photoselective vaporisation of the prostate using 80-W and 120-W laser versus transurethral resection of the prostate for benign prostatic hyperplasia: A systematic review with meta-analysis from 2002 to 2012. Eur Urol 2012; 60: 315–323.

Lourenco

Pickard

Vale

. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: Systematic review of randomised controlled trials. Brit Med J 2008; 337: a449.

Newbrander

Lewis

. Hospital costing model manual. Report for USAID Health Reform and Financing Program & APHIA Financing and Sustainability Project. Management Sciences for Health, 1999.

Al-Ansari

Younes

Pai Sampige

. Greenlight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: A randomized clinical trial with midterm follow-up. Eur Urol 2010; 58: 349–355.

Capitan

Blazquez

Martin

. Greenlight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: A randomized clinical trial with 2-year follow-up. Eur Urol 2011; 60: 734–739.

Lukacs

Loeffler

Bruyere

. Photoselective vaporization of the prostate with Greenlight 120-W laser compared with monopolar transurethral resection of the prostate: A multicentre randomized controlled trial. Eur Urol 2012; 61:1165–1173.

Teng

Zhang

Yao

. Photoselective vaporization with the green light laser vs transurethral resection of the prostate for treating benign prostate hyperplasia: A systematic review and meta-analysis. BJU Int 2013;111: 312–323.

10.

Bouchier-Hayes

Van Appledom

Bugeja

. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1 year follow-up. BJU Int 2009;105: 964–969.

11.

Stovsky

Griffiths

Duff

. A clinical outcomes and cost analysis comparing Photoselective Vaporization of the prostate to alternate minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia. J Urol 2006; 176: 1500–1506.

12.

Stafinski

Menon

Harris

. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia. CUAJ 2008; 2: 1–25.

13.

Goh

Gonzalez

. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: A cost analysis. J Urol 2010; 183: 1469–1473.

14.

Liatsikos

Kyriazis

Kallidonis

. Photoselective greenlight laser vaporization versus transurethral resection of the prostate in Greece: A comparative cost analysis. J Endourol 2012; 26: 168–173.

15.

Whitty

Crosland

Hewson

. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia. BJU Int 2013; [Epub ahead of print 10 April 2013. DOI: 10.1111/bju.12051].

16.

Taheri

Butz

Greenfield

. Length of stay has minimal impact on the cost of hospital admission. J Am Coll Surg 2000; 191: 123–130.

17.

Macario

. What does one minute of operating room time cost? J Clin Anes 2010; 22: 233–236.

18.

Mir

Cadeddu

Sleeper

. Cost comparison of robotic, laparoscopic, and open partial nephrectomy. J Endourol 2011; 25: 447–453.

19.

Ruszat

Wyler

Seitz

. Comparison of potassium-titanyl-phosphate laser vaporization of the prostate and transurethral resection of the prostate: Update of a prospective non-randomized two-centre study. BJU Int 2008; 102: 1432–1439.

20.

Lynch

Sriprasad

Subramonian

. Postoperative haemorrhage following transurethral resection of the prostate (TURP) and photoselective vaporisation of the prostate (PVP). Ann R Coll Surg Engl 2010; 92: 555–558.

21.

Muir

Sancha

Bachmann

. Techniques and training with Greenlight HPS 120-W laser therapy of the prostate: Position paper. Eur Urol 2008; S7: 370–377.

22.

Ben-Zvi

Hueber

Liberman

. GreenLight XPS 180W vs HPS 120W laser therapy for benign prostate hyperplasia: A prospective comparative analysis after 200 cases in a single-center study. Urology 2013; 81: 853–858.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB